Advice
Recommended for general use within NHS Scotland
RECOMMENDATION
Limited data indicate comparable efficacy and similar or better tolerability of calcitriol compared to existing topical vitamin D analogues in the treatment of mild to moderate plaque psoriasis in adults.
As calcitriol ointment is a substitute for existing medicines that have similar or increased costs, it is assumed that the net budget impact to the NHS will be minimal.
Download detailed advice21KB (PDF)
Medicine details
- Medicine name:
- Calcitriol 3ug/g for psoriasis (Silkis Ointment®)
- SMC ID:
- 43/03
- Indication:
- Mild-moderate plaque psoriasis
- Pharmaceutical company
- Galderma (UK) Ltd
- BNF chapter
- Skin
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 09 May 2003